Q2 Earnings Beat Overshadowed by Negative Free Cash Flow and Inventory Build

What happened

Ingram Micro's Q2 results exceeded expectations with net sales up 13.6% and non-GAAP EPS up 34.4%, but the stock fell 7% due to significant negative free cash flow from inventory build. The company's adjusted operating income grew 40%, suggesting improved operating leverage, while ROIC improved to 10.8%. However, the negative free cash flow pattern continues, following a -$0.94B FCF in Q1, and the inventory build raises concerns about demand sustainability. The DeepValue report maintained a WAIT rating due to thin margins (1.60% operating margin in Q1) and AI infrastructure mix pressure. This Q2 report provides some positive momentum but does not resolve the key risks of margin compression and sponsor secondary overhang.

Implication

The Q2 results show that Xvantage automation may be starting to deliver SG&A leverage, but the negative free cash flow indicates that the company is tying up cash in inventory, which could reverse if demand softens. The 40% adjusted operating income growth is a positive sign, but it remains to be seen if this is sustainable given the AI hardware mix pressure that previously compressed gross margins. The sponsor secondary overhang remains a risk, with limited buyback capacity ($70M after May 2026) and Platinum still holding ~80% voting power, which could cap multiple expansion. Investors should watch for gross margin stabilization and operating margin holding above 1.60% in the next quarterly report. Until there is evidence of sustainable margin improvement and normalized free cash flow, the stock remains a WAIT at current levels, with an attractive entry closer to $24.

Thesis delta

The Q2 earnings beat and improved operating income slightly strengthen the near-term outlook. However, the negative free cash flow from inventory build and unresolved AI mix pressure keep the thesis unchanged. The WAIT rating remains appropriate until the next quarterly report confirms margin stability and FCF normalization.